Free Trial

Edgestream Partners L.P. Purchases New Position in Maximus, Inc. (NYSE:MMS)

Maximus logo with Business Services background
Remove Ads

Edgestream Partners L.P. bought a new position in Maximus, Inc. (NYSE:MMS - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 7,608 shares of the health services provider's stock, valued at approximately $568,000.

Other large investors have also recently made changes to their positions in the company. UMB Bank n.a. increased its holdings in shares of Maximus by 79.8% in the fourth quarter. UMB Bank n.a. now owns 356 shares of the health services provider's stock worth $27,000 after purchasing an additional 158 shares during the last quarter. Eastern Bank bought a new stake in shares of Maximus in the fourth quarter worth about $29,000. V Square Quantitative Management LLC increased its holdings in shares of Maximus by 65.9% in the fourth quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider's stock worth $34,000 after purchasing an additional 180 shares during the last quarter. R Squared Ltd bought a new stake in shares of Maximus in the fourth quarter worth about $54,000. Finally, IFP Advisors Inc increased its holdings in shares of Maximus by 62.4% in the fourth quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock worth $59,000 after purchasing an additional 302 shares during the last quarter. 97.21% of the stock is owned by institutional investors.

Maximus Trading Up 0.3 %

NYSE MMS traded up $0.22 during trading hours on Friday, hitting $67.06. 457,007 shares of the company were exchanged, compared to its average volume of 481,849. The stock has a 50-day moving average price of $72.01 and a 200 day moving average price of $79.39. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.82. Maximus, Inc. has a 52 week low of $63.77 and a 52 week high of $93.97. The stock has a market cap of $3.80 billion, a PE ratio of 14.42 and a beta of 0.71.

Remove Ads

Maximus (NYSE:MMS - Get Free Report) last issued its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. Analysts forecast that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Saturday, February 15th were given a dividend of $0.30 per share. The ex-dividend date was Friday, February 14th. This represents a $1.20 annualized dividend and a dividend yield of 1.79%. Maximus's dividend payout ratio (DPR) is presently 25.81%.

Analyst Ratings Changes

MMS has been the topic of several research reports. StockNews.com cut Maximus from a "buy" rating to a "hold" rating in a report on Friday, February 14th. Raymond James raised Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price objective on the stock in a research note on Thursday, January 2nd.

View Our Latest Analysis on Maximus

Insider Buying and Selling at Maximus

In other Maximus news, insider Ilene R. Baylinson sold 14,500 shares of the business's stock in a transaction that occurred on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total transaction of $988,030.00. Following the completion of the transaction, the insider now owns 2,512 shares in the company, valued at $171,167.68. The trade was a 85.23 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Bruce Caswell bought 3,500 shares of the company's stock in a transaction on Tuesday, December 17th. The shares were acquired at an average price of $70.64 per share, with a total value of $247,240.00. Following the transaction, the chief executive officer now directly owns 275,929 shares of the company's stock, valued at approximately $19,491,624.56. This trade represents a 1.28 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Company insiders own 1.60% of the company's stock.

About Maximus

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Featured Articles

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Should You Invest $1,000 in Maximus Right Now?

Before you consider Maximus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.

While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

7 Inflation-Proof Stocks to Protect Your Portfolio

7 Inflation-Proof Stocks to Protect Your Portfolio

Inflation is sticking around—is your portfolio ready? In this video, we break down 7 stocks that could help shield your investments from inflation’s impact.

Related Videos

7 Large-Cap Stocks Headed for Strong, Steady Gains in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads